CLINICAL_TRIALS trial_result · 2019-08-14

Clinical Trial Update: A Phase IIa Multi-Center Study of 18F-FDG PET, Safety, and Tolerability of AZD0530 in Mild Alzheimer's Disease [Phase 2]

Phase IIa study assessing 18F-FDG PET, safety, and tolerability of AZD0530 in mild Alzheimer's disease completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Yale University | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED | Results posted: 2019-08-14